PL2276498T3 - Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii - Google Patents

Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii

Info

Publication number
PL2276498T3
PL2276498T3 PL09745633T PL09745633T PL2276498T3 PL 2276498 T3 PL2276498 T3 PL 2276498T3 PL 09745633 T PL09745633 T PL 09745633T PL 09745633 T PL09745633 T PL 09745633T PL 2276498 T3 PL2276498 T3 PL 2276498T3
Authority
PL
Poland
Prior art keywords
hyperhomocysteinaemia
treatment
probiotic bacteria
probiotic
bacteria
Prior art date
Application number
PL09745633T
Other languages
English (en)
Inventor
Giovanni Mogna
Gian Paolo Strozzi
Original Assignee
Probiotical S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probiotical S.P.A. filed Critical Probiotical S.P.A.
Publication of PL2276498T3 publication Critical patent/PL2276498T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL09745633T 2008-05-16 2009-04-08 Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii PL2276498T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000898A ITMI20080898A1 (it) 2008-05-16 2008-05-16 Uso di batteri probiotici per il trattamento della iperomocisteinemia
EP09745633.9A EP2276498B1 (en) 2008-05-16 2009-04-08 Use of probiotic bacteria for the treatment of hyperhomocysteinaemia

Publications (1)

Publication Number Publication Date
PL2276498T3 true PL2276498T3 (pl) 2017-08-31

Family

ID=40302761

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09745633T PL2276498T3 (pl) 2008-05-16 2009-04-08 Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii

Country Status (11)

Country Link
US (1) US20110135608A1 (pl)
EP (1) EP2276498B1 (pl)
JP (1) JP2011520821A (pl)
CN (1) CN102099044B (pl)
BR (1) BRPI0912687A2 (pl)
DK (1) DK2276498T3 (pl)
ES (1) ES2608758T3 (pl)
IT (1) ITMI20080898A1 (pl)
PL (1) PL2276498T3 (pl)
RU (1) RU2010147885A (pl)
WO (1) WO2009138300A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011044934A1 (en) * 2009-10-14 2011-04-21 Probiotical S.P.A Probiotic bacteria strains enabling of hydrolyzing prebiotic fibers and symbiotic compositions thereof
IT1401460B1 (it) * 2010-06-11 2013-07-26 Probiotical Spa "ceppi di batteri probiotici produttori di vitamina b12"
CN102429920A (zh) * 2011-11-30 2012-05-02 胡志超 一种多关联降血酸组合物及其制备方法
ITMI20112238A1 (it) * 2011-12-09 2013-06-10 Probiotical Spa Ceppi di batteri probiotici produttori di vitamina b12
DK3194567T3 (da) * 2014-08-29 2020-01-13 Chr Hansen As Probiotiske Bifidobacterium adolescentis-stammer
US20170326186A1 (en) * 2014-11-26 2017-11-16 Probiotical S.P.A. Strains of lactobacillus and bifidobacteria for the maintenance of a long-lasting homeostasis condition in a human body
ES2737712T3 (es) 2014-12-29 2020-01-15 Mofin S R L Producción de una pizza sin levadura, altamente digerible, usando una masa que contiene bacterias ácido lácticas
CN107772458A (zh) * 2017-09-29 2018-03-09 赤峰赛佰诺制药有限公司 一种用于高同型半胱氨酸血症的配方粉及其制备方法
CN115177641A (zh) * 2021-04-07 2022-10-14 深圳奥萨制药有限公司 一种用于辅助控制高血压的组合物
CN113398151A (zh) * 2021-06-29 2021-09-17 苏州麦若尔生物科技有限公司 一种用于治疗高同型半胱氨酸血症的益生菌与益生元结合发酵乳及其制备方法和用途
CN115181683B (zh) * 2022-02-10 2023-10-03 江南大学 一株高富集有机锌的短双歧杆菌

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1383829A (zh) * 2001-05-08 2002-12-11 肖钢 用于预防或治疗高同型半胱氨酸血症及其相关疾病的复方叶酸制剂
ES2290762T3 (es) * 2004-08-05 2008-02-16 Anidral S.R.L. Cepas bacterianas de bifidobacterium que producen acido folico, sus formulaciones y utilizacion.
WO2006102536A2 (en) * 2005-03-23 2006-09-28 University Of Southern California Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth
ITMI20061841A1 (it) * 2006-09-27 2008-03-28 Mofin S R L Colture liquide microbiche ad elevata stabilita' ed attivita' fermentativa
JP5140791B2 (ja) * 2008-11-27 2013-02-13 森下仁丹株式会社 乳酸菌含有血中ホモシステイン低減剤

Also Published As

Publication number Publication date
CN102099044B (zh) 2014-06-11
DK2276498T3 (en) 2016-12-12
EP2276498A1 (en) 2011-01-26
ES2608758T3 (es) 2017-04-12
BRPI0912687A2 (pt) 2016-01-26
CN102099044A (zh) 2011-06-15
EP2276498B1 (en) 2016-10-19
JP2011520821A (ja) 2011-07-21
US20110135608A1 (en) 2011-06-09
ITMI20080898A1 (it) 2009-11-17
WO2009138300A1 (en) 2009-11-19
RU2010147885A (ru) 2012-06-27

Similar Documents

Publication Publication Date Title
PL2276498T3 (pl) Zastosowanie bakterii probiotycznych do leczenia hiperhomocysteinemii
EP2273989A4 (en) POLYTHERAPY FOR THE TREATMENT OF BACTERIAL INFECTIONS
EP2129369A4 (en) TREATMENT OF ADHD
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
IL208354A0 (en) Methods of treatment
IL213619A0 (en) Treatment
GB0802116D0 (en) Treatment
GB0823480D0 (en) Devices for the treatment of fluids
GB0822011D0 (en) Treatment
IL205137A0 (en) 5-cyanothienopyridines for the treatment of tumours
GB0811992D0 (en) Treatment
IL207965A (en) Compounds to treat or prevent pain
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
GB0822486D0 (en) Compounds for use in the treatment of pain
EP2164494A4 (en) Methods of Treatment
EP2252306A4 (en) NEW USE OF PROBIOTICS
GB0723100D0 (en) Treatment of HFnEF
IL202506A0 (en) Neramexane for the treatment of nystagmus
PL2326551T3 (pl) Urządzenie do uzdatniania ścieków
GB0820972D0 (en) Treatment
PT2637974T (pt) Composição multifuncional para o tratamento de desinfecção da água e utilização desta composição
GB0805912D0 (en) Treatment
PL2229943T3 (pl) Związek do zastosowania w leczeniu neuropatii obwodowych
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
ZA201005770B (en) The treatment of damaged skin